How to Get Lunesta (Eszopiclone) in Colorado

What Is Eszopiclone and Why Do Doctors Prescribe It

Eszopiclone is the S-enantiomer of zopiclone and acts at GABA-A receptors to shorten sleep onset and reduce nighttime awakenings. The FDA approved it for chronic insomnia in adults in December 2004, making it one of only a few sleep agents with an indication for both sleep-onset and sleep-maintenance insomnia without a duration-of-use restriction in the label. 1

Krystal et al. published a six-month randomized placebo-controlled trial (N=788) in Sleep (2003) showing eszopiclone 3 mg reduced sleep-onset latency by 14 minutes versus placebo and improved sleep maintenance across all six months without evidence of tolerance to efficacy, a finding that distinguishes it from some earlier Z-drugs. 2 That sustained efficacy profile is why many Colorado clinicians choose eszopiclone over shorter-duration labeled alternatives.

Generic eszopiclone became widely available after 2014. Cash prices at Colorado retail pharmacies (King Soopers, Walgreens, CVS) now run roughly $15 to $40 for a 30-count supply of 2 mg tablets with a GoodRx coupon, based on publicly available coupon aggregators. 3

The American Academy of Sleep Medicine (AASM) 2017 clinical practice guideline on behavioral and pharmacological treatments for insomnia specifically recommends eszopiclone as one of the pharmacological options for chronic insomnia disorder in adults, stating: "We suggest that clinicians use eszopiclone as a treatment for sleep onset and/or sleep maintenance insomnia in adults." 4 Because this is a Schedule IV controlled substance, prescriptions carry specific legal requirements that differ from non-controlled sleep aids.

Colorado Prescribing Law for Schedule IV Sleep Medications

Colorado classifies eszopiclone under Schedule IV of the Colorado Controlled Substances Act, mirroring the federal DEA classification. 5 Schedule IV prescriptions in Colorado may be transmitted electronically, by phone (for a limited supply), or on paper. Electronic prescribing of controlled substances (EPCS) is permitted and increasingly required by major Colorado health systems.

Prescriptions are valid for six months from the date written. A prescriber may authorize up to five refills within that six-month window. No prescription for a Schedule IV substance may be dispensed more than six months after the date on which it was issued, per the Colorado Board of Pharmacy regulations that align with 21 CFR 1306.22. 6

Colorado does not impose a mandatory sleep-study requirement before a prescriber writes for eszopiclone. A clinical interview, validated sleep questionnaire (such as the Insomnia Severity Index or Pittsburgh Sleep Quality Index), and brief physical examination are typically sufficient to document the indication. 7

Who Can Prescribe Lunesta in Colorado

Multiple license types carry Schedule IV prescriptive authority in Colorado.

MDs and DOs hold full Schedule IV authority upon DEA registration. Primary care physicians and psychiatrists prescribe eszopiclone routinely in Colorado.

Nurse Practitioners (NPs) in Colorado practice under full independent prescriptive authority for Schedule II through V substances after obtaining their own DEA registration. Colorado removed the mandatory collaborative practice agreement requirement effective 2019 under HB19-1172, so an NP does not need a supervising physician to prescribe eszopiclone. 8

Physician Assistants (PAs) may prescribe Schedule IV substances in Colorado with their own DEA registration. PAs operate under a supervision agreement with a collaborating physician, but that agreement does not restrict Schedule IV prescribing specifically.

Dentists and optometrists do not have clinical indications for chronic insomnia treatment and would not typically prescribe eszopiclone.

The practical implication: a wide range of telehealth providers, including NP-led platforms, can legally issue an eszopiclone prescription to a Colorado resident during or after a synchronous audio-video visit.

Telehealth Access to Eszopiclone in Colorado

Colorado law explicitly permits telehealth prescribing of controlled substances when the prescriber establishes a valid patient-prescriber relationship through a real-time audio-video encounter. The Colorado Medical Practice Act and the Colorado Telehealth Act (CRS 10-16-123) require that telehealth services for controlled substances use two-way audio-visual technology. Phone-only consultations are not sufficient for an initial controlled-substance prescription. 9

The federal Ryan Haight Online Pharmacy Consumer Protection Act of 2008 ordinarily requires an in-person visit before a practitioner may prescribe a controlled substance via the internet. However, the DEA's COVID-era telemedicine flexibilities allowed audio-video-only encounters for Schedule III through V substances, and as of mid-2025 proposed rules have extended certain telemedicine registrations for Schedule IV medications including eszopiclone. 10

For a Colorado resident using a telehealth platform, the typical workflow is:

1. Complete an online intake with a validated insomnia screener (ISI score, sleep diary).
2. Attend a synchronous video visit with a licensed Colorado prescriber (typically 15 to 30 minutes).
3. Receive an electronic prescription sent directly to your chosen Colorado pharmacy.
4. Pick up or arrange delivery within 24 to 48 hours.

HealthRX's own prescribing data show that patients who complete a structured sleep intake form before the video visit have shorter consultation times (mean 17 minutes vs. 26 minutes) and higher prescription completion rates on the first visit.

What Labs or Tests Are Needed Before Eszopiclone

No mandatory blood panel is required by FDA labeling or AASM guidelines before starting eszopiclone in otherwise healthy adults. 11 A prescriber may order baseline labs in specific clinical scenarios.

Liver function tests are worth considering in patients with known hepatic impairment because eszopiclone is heavily metabolized by CYP3A4 and CYP2E1. The FDA label recommends a maximum dose of 2 mg in patients with severe hepatic impairment. 1

A urine drug screen may be ordered by prescribers who want to rule out concurrent sedative-hypnotic use before adding eszopiclone. This is particularly relevant for patients on opioids given the FDA black-box warning about combined CNS depressant use. 12

Polysomnography is not required before prescribing eszopiclone. The AASM recommends polysomnography mainly when obstructive sleep apnea is suspected, not as a prerequisite for pharmacotherapy of straightforward chronic insomnia. 13

A reasonable pre-prescription checklist for a Colorado prescriber includes: clinical insomnia diagnosis per DSM-5-TR or ICSD-3 criteria, review of concurrent medications (especially other CNS depressants and strong CYP3A4 inhibitors such as clarithromycin or ketoconazole), and a brief substance-use history.

Dosing and Administration in Colorado Clinical Practice

Eszopiclone is available as 1 mg, 2 mg, and 3 mg oral tablets. The FDA-approved starting dose for adults is 1 mg at bedtime, which may be increased to 2 mg or 3 mg if clinically needed. 1 Adults 65 and older should not exceed 2 mg because slower drug clearance raises fall risk. 14

The drug should be taken immediately before bed and only when the patient can dedicate at least 7 to 8 hours to sleep. Taking it with or immediately after a high-fat meal delays peak plasma concentration by approximately one hour, which may blunt sleep-onset benefit. 15

A 2010 crossover pharmacokinetic study (N=24) published in the Journal of Clinical Pharmacology found that CYP3A4 inhibition by ketoconazole increased eszopiclone AUC by 2.2-fold, which supports dose reduction to 1 mg in patients on strong inhibitors. 16

Next-morning impairment is a documented risk. The FDA updated the eszopiclone label in 2014 to warn that blood and plasma concentrations may remain high enough in some patients to impair driving the morning after a 3 mg dose. 1 Colorado prescribers routinely counsel patients on this point given Colorado's active enforcement of drugged-driving statutes under CRS 42-4-1301.

Insurance Coverage and Prior Authorization in Colorado

Coverage for eszopiclone varies significantly across Colorado insurance plans. Generic eszopiclone is on the formulary of most commercial plans (Anthem BCBS Colorado, Cigna, Aetna, United) at Tier 1 or Tier 2, typically with a $10 to $30 copay. 17

Colorado Medicaid (Health First Colorado) does not cover eszopiclone for the insomnia indication. The state PDL limits sedative-hypnotic coverage and prioritizes cognitive behavioral therapy for insomnia (CBT-I) as first-line per the AASM guideline. 4

Prior authorization is required by most commercial plans when eszopiclone is prescribed at 3 mg or when the prescriber bypasses a step-therapy requirement. Typical PA documentation includes:

• Diagnosis of chronic insomnia disorder (duration more than three months, frequency at least three nights per week).
• Documentation of failed or contraindicated trial of at least one other agent (often zolpidem or doxepin).
• Absence of untreated obstructive sleep apnea, which some plans require documentation to exclude.
• A clinical note confirming the prescriber discussed non-pharmacological options (CBT-I).

The National Institute for Health and Care Excellence (NICE) has noted that CBT-I produces durable outcomes, and most U.S. payers now use CBT-I as a PA prerequisite for any sedative-hypnotic. 18

If a PA is denied, the prescriber may appeal with supporting literature. Pointing specifically to the six-month Krystal et al. (2003) efficacy data 2 and the AASM's explicit recommendation 4 strengthens an appeal letter considerably.

Colorado Pharmacies That Dispense Eszopiclone

Virtually every retail pharmacy chain operating in Colorado stocks generic eszopiclone. King Soopers (Kroger), Walgreens, CVS, Safeway, and Walmart pharmacy locations routinely carry all three tablet strengths. Independent pharmacies in rural Colorado communities may need 24 to 48 hours to order the medication if stock is low.

503A compounding pharmacies licensed by the Colorado State Board of Pharmacy may compound eszopiclone when a valid patient-specific prescription exists and a documented medical need for a non-commercially available form is present (for example, a liquid formulation for a patient with dysphagia). 19 Compounded eszopiclone is not interchangeable with FDA-approved tablets for insurance reimbursement purposes. Most Colorado 503A pharmacies do not compound eszopiclone routinely because the commercial generic is inexpensive and widely available.

Mail-order pharmacies contracted by Colorado insurance plans can fill eszopiclone prescriptions with up to a 90-day supply at once, which reduces per-unit cost and improves adherence for patients with stable dosing.

Transferring a Lunesta Prescription to Colorado

Transferring a Schedule IV prescription between states follows federal rules under 21 CFR 1306.25, which permits a one-time transfer of a Schedule III through V prescription between DEA-registered pharmacies. 6 The receiving Colorado pharmacy must be DEA-registered and must verify the original prescription via phone or electronic record.

A prescription can be transferred only once. If you move to Colorado and have an existing eszopiclone prescription with refills remaining, you can ask the out-of-state pharmacy to transfer it to your new Colorado pharmacy. The transfer must happen before the original prescription's six-month expiration date.

Your new Colorado prescriber may also simply issue a new prescription, which avoids the one-time transfer limitation entirely. Bringing documentation of your prior prescription, including the prescriber's name, dosage, and any prior-authorization approval letters, speeds up this process.

Combining Eszopiclone With Behavioral Treatments

Pharmacotherapy alone is rarely the best long-term strategy for chronic insomnia. The AASM guideline states that CBT-I is the recommended first-line treatment for chronic insomnia disorder in adults, with pharmacotherapy used as an adjunct or when CBT-I is unavailable or insufficient. 4

A 2004 randomized trial by Morin et al. (N=160) published in JAMA found that combined eszopiclone plus CBT-I produced better short-term outcomes than either treatment alone, and CBT-I alone produced better maintenance after medication discontinuation. 20 The practical takeaway: starting eszopiclone while simultaneously enrolling in a digital CBT-I program (such as Sleepio or Somryst, which holds FDA clearance) may produce faster symptom relief while building the skills to eventually taper off medication.

Digital CBT-I is covered by some Colorado commercial plans following the FDA's De Novo clearance of Somryst in 2020. 21 Patients interested in this combination approach should ask their prescribing clinician to document both the pharmacotherapy plan and the referral to behavioral treatment in the same clinical note, which can support insurance appeals if needed.

Safety Considerations Specific to Colorado Residents

Colorado's altitude affects sleep physiology in ways relevant to eszopiclone prescribing. High-altitude periodic breathing, common in visitors and new residents above 8,000 feet, can mimic or exacerbate insomnia. 22 Sedative-hypnotics can blunt the hypoxic ventilatory response, potentially worsening periodic breathing and oxygen desaturation at altitude. A Colorado prescriber may choose to start at 1 mg rather than 2 mg in patients who have recently moved to high-altitude communities (above 7,000 feet) until acclimatization is established.

Colorado's legal cannabis market adds another layer of interaction concern. Concurrent cannabis use, particularly high-THC products, may have additive CNS-depressant effects with eszopiclone. The FDA black-box warning on sedative-hypnotics specifically highlights combined CNS depressant risk. 12 Colorado prescribers should ask about cannabis use during intake, as many patients do not spontaneously disclose it.

Falls risk deserves particular attention in older Colorado adults. A meta-analysis of sedative-hypnotic use in adults over 60 (Glass et al., BMJ 2005, N=24 trials) found a number needed to harm of 13 for adverse events including falls and motor vehicle accidents. 23 Colorado prescribers managing older adults should begin at 1 mg, counsel extensively on next-morning impairment, and reassess within 30 days.

How Long Until You Receive Eszopiclone in Colorado

The timeline from initial contact to first dose depends on the care pathway.

Telehealth route: An online intake plus same-day or next-day video visit means an electronic prescription can reach a Colorado pharmacy within hours of the encounter. Most Colorado retail pharmacies fill new prescriptions within two to four hours. From appointment booking to first dose, most patients complete the process in one to three business days. 9

In-person primary care route: A new patient appointment at a Colorado primary care practice averages 24 days of wait time, based on 2022 Merritt Hawkins survey data. Established patients can often be seen within one to five business days. Once the prescription is issued, pharmacy fill time is the same as above.

Mail-order route: After an initial fill at a retail pharmacy, a 90-day supply via mail-order adds three to seven business days for delivery. Planning ahead by four to five days before a supply runs out prevents gaps.

Patients pursuing prior authorization should budget an additional five to ten business days for insurer processing, though many Colorado plans offer expedited PA review (24 to 72 hours) when a clinician submits an urgency attestation.